Darin Lippoldt

Conseiller Juridique Général chez NEUROCRINE BIOSCIENCES, INC.

Fortune : 5 M $ au 30/04/2024

58 ans

Health Technology

Consumer Services

Postes actifs de Darin Lippoldt

Sociétés	Poste	Début	Fin
NEUROCRINE BIOSCIENCES, INC.	Conseiller Juridique Général	01/10/2014	-
NEUROCRINE BIOSCIENCES, INC.	Secrétaire Général	01/10/2014	-

Sociétés	Poste	Début	Fin
VOLCANO CORPORATION	Compliance Officer	01/08/2010	01/10/2014
	Conseiller Juridique Général	19/11/2010	01/10/2014
	Secrétaire Général	01/08/2010	01/10/2014
Amylin Pharmaceuticals, Inc. Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA.	Corporate Officer/Principal	01/11/2003	01/07/2010

St. Mary's University

Undergraduate Degree

Internationale

Etats-Unis

Opérationnelle

Sectorielle

Health Technology	4
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
NEUROCRINE BIOSCIENCES, INC.	Health Technology

Entreprise privées	2
Philips Image Guided Therapy Corp. Philips Image Guided Therapy Corp. Medical SpecialtiesHealth Technology Volcano Corp. designs, develops and manufactures a broad suite of intravascular ultrasound products. The company was founded by Olav B. Bergheim and Samuel Ward Casscells and is headquartered in San Diego, CA.	Health Technology
Amylin Pharmaceuticals, Inc. Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA.	Health Technology